Feverfew (Tanacetum parthenium) as a pro
β
D. Palevitch; G. Earon; R. Carasso
π
Article
π
1997
π
John Wiley and Sons
π
English
β 65 KB
To assess the effectiveness of feverfew as a prophylactic therapy for migraine, a double-blind placebo controlled cross-over trial was conducted for a period of 4 months. Fifty seven patients who attended an outpatient pain clinic were selected at random and divided into two groups. Both groups were